Impact of pretreatment cholinesterase level on survival of inoperable intrahepatic or hepatic-hilar carcinomas treated with three-dimensional conformal radiotherapy

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 22, Issue 5, 2004, Pages 316-323

  Hamamoto, Yasushi ^a,c   Niino, Keiji ^b   Ishiyama, Hiromichi ^b   Hosoya, Takaaki ^b  

^a National Hospital Organization   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c National Hospital Organization   (Japan)

Author keywords

Conformal radiotherapy; Hepatic carcinoma; Prognostic factor

Indexed keywords

CHOLINESTERASE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHOLINESTERASE BLOOD LEVEL; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MALE; RADIATION DOSE; SURVIVAL RATE; THREE DIMENSIONAL CONFORMAL RADIOTHERAPY;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; CHOLINESTERASES; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, HIGH-ENERGY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 7944221153     PISSN: 02882043     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Cheng JC, Wu JK, Huang CM, et al. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication. Int J Radiat Oncol Biol Phys, 54: 156-162, 2002.
2. Dawson LA, McGinn CJ, Normolle D, et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol, 18: 2210-2218, 2000.
3. Seong J, Park HC, Han KH, Chon CY. Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients. Int J Radiat Oncol Biol Phys, 55: 329-336, 2003.
4. Cheng JC, Chuang VP, Cheng SH, et al. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys, 47: 435-442, 2000.
5. Dawson LA, Normolle D, Balter JM, McGinn CJ, Lawrence TS, Ten Haken RK. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys, 53: 810-821, 2002.
6. Fanner DG, Rosove MH, Snaked A, Busuttil RW. Current treatment modalities for hepatocellular carcinoma. Ann Surg, 219: 236-247, 1994.
7. Dawson LA, Ten Haken RK, Lawrence TS. Partial irradiation of the liver. Semin Radiat Oncol, 11: 240-246, 2001.
8. Robertson JM, Lawrence TS, Dworzanin LM, et al. Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy. J Clin Oncol, 11: 1286-1293, 1993.
9. Robertson JM, Lawrence TS, Walker S, Kessler ML, Andrews JC, Ensminger WD. The treatment of colorectal liver metastases with conformal radiation therapy and regional chemotherapy. Int J Radiat Oncol Biol Phys, 32: 445-450, 1995.
10. Robertson JM, Lawrence TS, Andrews JC, Walker S, Kessler ML, Ensminger WD. Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers. Int J Radiat Oncol Biol Phys, 37: 325-330, 1997.
11. Park HC, Seong J, Ran KH, Chon CY, Moon YM, Suh CO. Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys, 54: 150-155, 2002.
12. Lawrence TS, Ten Haken RK, Kessler ML, et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys, 23: 781-788, 1992.
13. Cheng JC, Wu JK, Huang CM, et al. Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description. Radiother Oncol, 63: 41-45, 2002.
14. Ohara K, Tsuji H, Tatsuzaki H, et al. Radiation tolerance of the liver in relation to the preserved functional capacity. Acta Oncol, 33: 819-823, 1994.
15. Ohara K, Okumura T, Tsuji H, et al. Radiation tolerance of cirrhotic livers in relation to the preserved functional capacity: analysis of patients with hepatocellular carcinoma treated by focused proton beam radiotherapy. Int J Radiat Oncol Biol Phys, 38: 367-372, 1997.
16. Crane CH, Macdonald KO, Vauthey JN, et al. Limitations of conventional doses of chemoradiation for unresectable biliary cancer. Int J Radiat Oncol Biol Phys, 53: 969-974, 2002.